Clinical Trial Update: Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating adding cemiplimab to preoperative chemotherapy for sinonasal squamous cell carcinoma; recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sinonasal Squamous Cell Carcinoma

Drugs mentioned

• Cemiplimab (cemiplimab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Sinonasal Squamous Cell Carcinoma, Stage III Sinonasal Cancer AJCC v8 | Phase 2 | Status: RECRUITING